Rare diseases
Investigational molecules
Locations
A study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
BulgariaA Study of Brenipatide Compared to Placebo for Adults with Uncontrolled Moderate to Severe Asthma
FranceA study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness
BulgariaLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
BelgiumA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
AustriaA study of navenibart for long-term safety in patients with hereditary angioedema
AustriaA study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors
AustriaA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
AustriaA study testing duvakitug for patients with moderately to severely active ulcerative colitis
AustriaA Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis
CzechiaA Study of Visugromab Compared to Placebo in Patients with Cancer-Related Cachexia to Test How Well It Works and How Safe It Is
BulgariaA Study of Darovasertib Before Surgery or Radiation Therapy for Patients with Early-Stage Uveal Melanoma That Has Not Spread
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
